ADX-102 Ophthalmic Solution (0.5%)

DRUG2 trials

Sponsors

Aldeyra Therapeutics, Inc.

Conditions

Dry Eye SyndromesNon-infectious Anterior Uveitis

Phase 2

A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome

CompletedNCT03162783

Aldeyra Therapeutics, Inc.Dry Eye Syndromes

Start: 2017-05-15End: 2017-07-06Updated: 2025-01-16

Phase 3

SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.

CompletedNCT03131154

Aldeyra Therapeutics, Inc.Non-infectious Anterior Uveitis

Start: 2017-04-26End: 2019-04-26Updated: 2025-02-10

Related Papers

A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease

Journal of Ocular Pharmacology and Therapeutics2021-01-1533 citations